Patents by Inventor Giovanni Paternostro

Giovanni Paternostro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10095842
    Abstract: Methods and systems for determining a set of control molecules for use in a combinatorial approach for the treatment of medical conditions, including providing one or more sets of control molecules, where each control molecule within the set acts on a set of targets and the number of control molecules within the one or more sets of control molecules is fewer than the number of targets within the sets of targets; and searching within the sets of control molecules to identify a subset of control molecules that together with a subset of targets form an artificial system to produce a biological effect through the modulation of the subset of targets.
    Type: Grant
    Filed: May 28, 2011
    Date of Patent: October 9, 2018
    Assignee: SALGOMED, INC.
    Inventors: Giovanni Paternostro, Jacob D Feala
  • Publication number: 20120015834
    Abstract: Methods and systems for determining a set of control molecules for use in a combinatorial approach for the treatment of medical conditions, including providing one or more sets of control molecules, where each control molecule within the set acts on a set of targets and the number of control molecules within the one or more sets of control molecules is fewer than the number of targets within the sets of targets; and searching within the sets of control molecules to identify a subset of control molecules that together with a subset of targets form an artificial system to produce a biological effect through the modulation of the subset of targets.
    Type: Application
    Filed: May 28, 2011
    Publication date: January 19, 2012
    Inventors: Giovanni Paternostro, Jacob D. Feala
  • Publication number: 20090087497
    Abstract: Compositions and methods are provided that are based on a discovery that a combination of three compounds, doxycycline, selenium, and zinc, retards physiological age-related changes (for example cardiac aging and the decline in exercise capacity) and can also prolong survival.
    Type: Application
    Filed: August 18, 2008
    Publication date: April 2, 2009
    Applicant: Burnham Institute for Medical Research
    Inventor: Giovanni Paternostro
  • Patent number: 7087021
    Abstract: The relationship between aging and decreased cardiac function is well known. However, the human cardiac system is extremely complex and humans are very long-lived animals. Therefore, there is a need for simple models of the heart that can be rapidly tested over time. The fruit fly Drosophila melanogaster has served as a valuable model-organism for the study of aging and is the first organism possessing a circulatory system to have its genome completely sequenced. The present inventor has found that maximal heart rate is significantly and reproducibly reduced with aging in Drosophila, analogous to observations in elderly humans. The present inventor has also described several other aspects of the cardiac physiology of young adult and aging Drosophila, including an age-associated increase in rhythm disturbances. The present invention contemplates methods for studying cardiac function in vivo in adult flies.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: August 8, 2006
    Inventor: Giovanni Paternostro
  • Publication number: 20040187169
    Abstract: The present invention provides a novel method of screening for a gene or an agent affecting cardiac function after or during hypoxia or anoxia, including the steps of: providing an adult Drosophila in conditions able to induce hypoxia or anoxia, imaging the heart of the Drosophila, measuring the movements of the heart in the image, analyzing the measurements of the movements, and identifying a gene affecting the cardiac function of the Drosophila or identifying the effect of the agent on the cardiac function. The method may include administering an agent before, during or after hypoxia.
    Type: Application
    Filed: March 19, 2004
    Publication date: September 23, 2004
    Inventor: Giovanni Paternostro
  • Publication number: 20020161302
    Abstract: The relationship between aging and decreased cardiac function is well known. However, the human cardiac system is extremely complex and humans are very long-lived animals. Therefore, there is a need for simple models of the heart that can be rapidly tested over time. The fruit fly Drosophila melanogaster has served as a valuable model-organism for the study of aging and is the first organism possessing a circulatory system to have its genome completely sequenced. The present inventor has found that maximal heart rate is significantly and reproducibly reduced with aging in Drosophila, analogous to observations in elderly humans. The present inventor has also described several other aspects of the cardiac physiology of young adult and aging Drosophila, including an age-associated increase in rhythm disturbances. The present invention contemplates methods for studying cardiac function in vivo in adult flies.
    Type: Application
    Filed: February 15, 2002
    Publication date: October 31, 2002
    Inventor: Giovanni Paternostro